Christoph Peters
Freiburg, BW 79104, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Specificity profiling of SARS-CoV-2 PLpro using proteome-derived libraries of linear peptides suggests secondary preference for basic motifs.
Journal: Archives of biochemistry and biophysics
Published: March 19, 2026
Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board
Journal: Pathologie (Heidelberg, Germany)
Published: April 30, 2025
Correction: Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity.
Journal: Oncogene
Published: February 11, 2025
Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
Journal: Journal of cancer research and clinical oncology
Published: January 18, 2025
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.
Journal: NPJ precision oncology
Published: April 29, 2024
The German Network for Personalized Medicine to enhance patient care and translational research.
Journal: Nature medicine
Published: June 06, 2023
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
Journal: Journal of cancer research and clinical oncology
Published: October 02, 2022
CTLA-2 Alpha Is a Potent Inhibitor of Angiogenesis in Murine Ocular Tissue.
Journal: Antioxidants (Basel, Switzerland)
Published: February 12, 2021
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.
Journal: ACS infectious diseases
Published: February 11, 2021
The secreted inhibitor of invasive cell growth CREG1 is negatively regulated by cathepsin proteases.
The secreted inhibitor of invasive cell growth CREG1 is negatively regulated by cathepsin proteases.
Journal: Cellular and molecular life sciences : CMLS
Published: September 24, 2019
Last Updated: 09/26/2026